Clinical efficacy and prognostic factors of endoscopic surgery for chronic suppurative otitis media: a retrospective cohort study.

IF 1.3 4区医学 Q3 OTORHINOLARYNGOLOGY

Acta Oto-Laryngologica Pub Date : 2026-08-01 Epub Date: 2026-03-13 DOI:10.1080/00016489.2026.2641824

Hao He, A Heng Wang, Yu Wu, Zhengping Xia

{"title":"Clinical efficacy and prognostic factors of endoscopic surgery for chronic suppurative otitis media: a retrospective cohort study.","authors":"Hao He, A Heng Wang, Yu Wu, Zhengping Xia","doi":"10.1080/00016489.2026.2641824","DOIUrl":null,"url":null,"abstract":"Background: Chronic suppurative otitis media (CSOM) is a significant global health concern, leading to persistent ear discharge and hearing loss.Aims/objectives: This study aimed to evaluate the clinical efficacy and safety of EES for CSOM and to identify independent prognostic factors influencing surgical success.Materials and methods: In this single-center retrospective cohort study, 180 patients undergoing EES for CSOM between 2022 and 2024 were enrolled. Data on demographics, clinical profiles, and surgical details were collected. Primary outcomes included dry ear rate, pure-tone average (PTA) improvement, and complications at 6 months post-surgery.Results: The 6-month dry ear rate was 91.1%. Mean PTA improved significantly by 24.8 ± 7.2 dB. The complication rate was 3.9%. Multivariate analysis identified cholesteatoma (HR = 3.24, 95% CI: 1.85-5.68, p < 0.001), disease duration >5 years (HR = 2.52, 95% CI: 1.45-4.38, p = 0.001), and preoperative PTA >50 dB (HR = 2.89, 95% CI: 1.65-5.06, p < 0.001) as independent risk factors for failure. Subgroup analyses confirmed the consistency of these factors.Conclusions and significance: Endoscopic ear surgery is an effective and safe treatment for CSOM in the mid-term (6-month) follow-up. Cholesteatoma, prolonged disease duration, and severe preoperative hearing loss are robust predictors of poorer outcomes.","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":" ","pages":"917-924"},"PeriodicalIF":1.3000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Oto-Laryngologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00016489.2026.2641824","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Chronic suppurative otitis media (CSOM) is a significant global health concern, leading to persistent ear discharge and hearing loss.

Aims/objectives: This study aimed to evaluate the clinical efficacy and safety of EES for CSOM and to identify independent prognostic factors influencing surgical success.

Materials and methods: In this single-center retrospective cohort study, 180 patients undergoing EES for CSOM between 2022 and 2024 were enrolled. Data on demographics, clinical profiles, and surgical details were collected. Primary outcomes included dry ear rate, pure-tone average (PTA) improvement, and complications at 6 months post-surgery.

Results: The 6-month dry ear rate was 91.1%. Mean PTA improved significantly by 24.8 ± 7.2 dB. The complication rate was 3.9%. Multivariate analysis identified cholesteatoma (HR = 3.24, 95% CI: 1.85-5.68, p < 0.001), disease duration >5 years (HR = 2.52, 95% CI: 1.45-4.38, p = 0.001), and preoperative PTA >50 dB (HR = 2.89, 95% CI: 1.65-5.06, p < 0.001) as independent risk factors for failure. Subgroup analyses confirmed the consistency of these factors.

Conclusions and significance: Endoscopic ear surgery is an effective and safe treatment for CSOM in the mid-term (6-month) follow-up. Cholesteatoma, prolonged disease duration, and severe preoperative hearing loss are robust predictors of poorer outcomes.

查看原文本刊更多论文

内镜手术治疗慢性化脓性中耳炎的临床疗效及预后因素：一项回顾性队列研究。

背景：慢性化脓性中耳炎（CSOM）是一个重要的全球健康问题，导致持续性耳部分泌物和听力损失。目的：本研究旨在评价EES治疗CSOM的临床疗效和安全性，并确定影响手术成功的独立预后因素。材料和方法：在这项单中心回顾性队列研究中，入组了180例在2022年至2024年间接受EES治疗的CSOM患者。收集了人口统计数据、临床资料和手术细节。主要结局包括术后6个月的干耳率、纯音平均（PTA）改善和并发症。结果：6个月干耳率为91.1%。平均PTA改善24.8±7.2 dB。并发症发生率为3.9%。多因素分析发现胆脂瘤（HR = 3.24, 95% CI: 1.85-5.68, p = 0.001），术前PTA bb0 50 dB (HR = 2.89, 95% CI: 1.65-5.06, p)，结论及意义：内窥镜耳部手术在中期（6个月）随访中是一种有效、安全的治疗CSOM的方法。胆脂瘤、病程延长和术前严重的听力损失是预后较差的可靠预测因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Oto-Laryngologica 医学-耳鼻喉科学

CiteScore

2.50

自引率

0.00%

发文量

审稿时长

3-6 weeks

期刊介绍： Acta Oto-Laryngologica is a truly international journal for translational otolaryngology and head- and neck surgery. The journal presents cutting-edge papers on clinical practice, clinical research and basic sciences. Acta also bridges the gap between clinical and basic research.